Literature DB >> 4966833

Purification and properties of in vitro-produced anthrax toxin components.

D C Fish, B G Mahlandt, J P Dobbs, R E Lincoln.   

Abstract

The three components of the toxin of Bacillus anthracis, edema factor (EF), protective antigen (PA), and lethal factor (LF), were purified 197-, 156-, and 1,025- fold, with 38, 78, and 11% recovery, respectively. Each purified component was serologically active, distinct, and free from the other components. The purified EF produced edema when mixed with PA, and the purified PA was an active immunogen. The components did not appear to be simple proteins by spectrophotometric analysis. As they were purified, the pH range in which they were most stable narrowed, centering between pH 7.4 and 7.8. Heat readily destroyed the biological activity of the components but not their serological activity. The rat lethality test showed that, with a constant amount of LF and an increasing amount of PA, the time to death reached a minimum and then was extended. When an increasing amount of LF was added to a constant amount of PA, the time to death became shorter as more LF was added. The biological, immunological, and serological properties of the components were shown to vary independently with storage and extent of purification so that serological activity was not always directly correlated with biological activity. Evidence is presented that the components can exist in different molecular configurations or as aggregates, and that this property is influenced by the state of component purity and by the environment.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4966833      PMCID: PMC252109          DOI: 10.1128/jb.95.3.907-918.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  Estimation of molecular weights of proteins by gel filtration.

Authors:  P ANDREWS
Journal:  Nature       Date:  1962-10-06       Impact factor: 49.962

2.  Purification of factor I and recognition of a third factor of the anthrax toxin.

Authors:  J L STANLEY; H SMITH
Journal:  J Gen Microbiol       Date:  1961-09

3.  Purification of the third factor of anthrax toxin.

Authors:  H SMITH; J L STANLEY
Journal:  J Gen Microbiol       Date:  1962-11

4.  The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity.

Authors:  J L STANLEY; H SMITH
Journal:  J Gen Microbiol       Date:  1963-05

5.  Purification of factors I and II of the anthrax toxin produced in vivo.

Authors:  J L STANLEY; K SARGEANT; H SMITH
Journal:  J Gen Microbiol       Date:  1960-02

6.  The use of bacteria grown in vivo for studies on the basis of their pathogenicity.

Authors:  H SMITH
Journal:  Annu Rev Microbiol       Date:  1958       Impact factor: 15.500

7.  Immunological studies of anthrax. I. An index to determine quantitative immunization.

Authors:  I A DEARMON; F KLEIN; R E LINCOLN; B G MAHLANDT; A L FERNELIUS
Journal:  J Immunol       Date:  1961-09       Impact factor: 5.422

8.  The effect of metabolite analogues on growth of Bacillus anthracis in the guinea pig and on the formation of virulence-determining factors.

Authors:  D W TEMPEST; H SMITH
Journal:  J Gen Microbiol       Date:  1957-12

9.  A simple ultraviolet spectrophotometric method for the determination of protein.

Authors:  W J WADDELL
Journal:  J Lab Clin Med       Date:  1956-08

10.  Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin.

Authors:  B G Mahlandt; F Klein; R E Lincoln; B W Haines; W I Jones; R H Friedman
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

View more
  27 in total

1.  Search for correlates of protective immunity conferred by anthrax vaccine.

Authors:  S Reuveny; M D White; Y Y Adar; Y Kafri; Z Altboum; Y Gozes; D Kobiler; A Shafferman; B Velan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

Authors:  L C Iacono-Connors; C S Schmaljohn; J M Dalrymple
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Serology and anthrax in humans, livestock and Etosha National Park wildlife.

Authors:  P C Turnbull; M Doganay; P M Lindeque; B Aygen; J McLaughlin
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

4.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

5.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin.

Authors:  S F Little; S H Leppla; E Cora
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

7.  In vivo-produced anthrax toxin.

Authors:  D C Fish; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

8.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Protective immunity induced by Bacillus anthracis toxin-deficient strains.

Authors:  C Pezard; M Weber; J C Sirard; P Berche; M Mock
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.